Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong · Delayed Price · Currency is HKD 19.38
+0.47 (2.49%)
At close: Mar 27, 2026
Qyuns Therapeutics Market Cap
Qyuns Therapeutics has a market cap or net worth of 4.35 billion as of March 27, 2026. Its market cap has increased by 179.97% in one year.
Market Cap
4.35B
Enterprise Value
4.43B
Revenue
897.99M
Ranking
n/a
PE Ratio
12.35
Stock Price
19.38
Market Cap Chart
Since March 20, 2024, Qyuns Therapeutics's market cap has decreased from 5.02B to 4.35B, a decrease of -13.24%. That is a compound annual growth rate of -6.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 4.25B | 0.25% |
| Dec 31, 2025 | 4.24B | 158.47% |
| Dec 31, 2024 | 1.64B | -67.33% |
| Mar 20, 2024 | 5.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jacobio Pharmaceuticals Group | 5.03B |
| Beijing Luzhu Biotechnology | 4.93B |
| BioDlink International Company | 4.23B |
| Shandong Boan Biotechnology | 4.00B |
| Viva Biotech Holdings | 3.93B |
| Mirxes Holding Company | 3.84B |
| TYK Medicines | 3.84B |
| AIM Vaccine | 3.41B |